PGUCX | VCRCX | PGUCX / VCRCX | |
Total Expense Ratio | 2.02 | 2.08 | 97% |
Annual Report Gross Expense Ratio | 2.02 | 2.10 | 96% |
Fund Existence | 20 years | 6 years | - |
Gain YTD | 7.381 | 6.443 | 115% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 1000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 147M | 882M | 17% |
Annual Yield % from dividends | 1.31 | 0.77 | 170% |
Returns for 1 year | 14.09 | 14.69 | 96% |
Returns for 3 years | -9.07 | 4.32 | -210% |
Returns for 5 years | 31.44 | 55.98 | 56% |
Returns for 10 years | 7.43 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIS | 19.65 | 0.70 | +3.69% |
ProShares UltraShort Nasdaq Biotech | |||
SPBO | 29.04 | 0.01 | +0.03% |
SPDR® Portfolio Corporate Bond ETF | |||
PTBD | 20.12 | -0.01 | -0.05% |
Pacer Trendpilot US Bond ETF | |||
FLSW | 35.42 | -0.10 | -0.28% |
Franklin FTSE Switzerland ETF | |||
PSFF | 28.01 | -0.70 | -2.44% |
Pacer Swan SOS Fund of Funds ETF |